Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LRRC32 antisense RNA 1 (LRRC32-AS1) is a long non-coding RNA transcribed from the antisense strand of the LRRC32 locus. It belongs to the class of antisense lncRNAs, molecules that may regulate the expression of their sense gene (here, LRRC32 encoding Glycoprotein A Repetitions Predominant, or GARP) or potentially act on other targets at the transcript or chromatin level[1][3][5]. While the biological role of LRRC32-AS1 itself remains uncharacterized in the referenced literature, it is structurally typical of nuclear antisense lncRNAs, which are increasingly recognized as regulators of gene transcription, chromatin organization, and possibly cell phenotype in health and disease[3][5]. No direct evidence links LRRC32-AS1 specifically to known diseases, drug interactions, or clinical biomarker roles at this time[1].
Not applicable; no drugs reported to target LRRC32-AS1 directly[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on LRRC32 antisense RNA 1 (LRRC32-AS1).